Editorial · 31 May 2025
Research articlePublished 31 Oct 2016
YM155 Suppresses Proliferation and Survival of Multiple Myeloma Cells via Proteasomal Degradation of c-Myc
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The overall survival of patients with multiple myeloma has significantly improved over the last decade, mainly due to the use of novel agents such as thalidomide, lenalidomide and bortezomib; however, multiple myeloma remains incurable due to its eventual relapse, necessitating urgent development of newer agents. YM155 is a novel small molecule that suppresses transactivation of survivin and induces apoptosis in various cancer cell types. However, the effects of YM155 on multiple myeloma cells have not been fully elucidated. We herein found that YM155 inhibited proliferation of and induced caspase-dependent apoptosis in myeloma cells, partially via the suppression of survivin, myeloid cell leukemia sequence-1, and X-linked inhibitor of apoptosis protein. Interestingly, YM155 suppressed c-Myc protein expression via the proteasomal degradation. Moreover, YM155 increased F-box and WD-40 domain protein 7α expression that is a component of the Skp, Cullin, F-box-like ubiquitin ligase complex, suggesting that YM155-induced c-Myc down-regulation may be due to the proteasomal degradation through ubiquitination by F-box and WD-40 domain protein 7α. These results warrant further clinical evaluation of YM155 in MM patients.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Medical Oncology and Therapeutics.
Opinion · 31 May 2025
The Importance of Early-Phase Clinical Trials in Developing New Cancer Therapies
Short communication · 31 May 2025
Understanding Cancer Drug Resistance: Mechanisms and Solutions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Medical Oncology and Therapeutics
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Maki Asahi”
- BylineArticles whose byline prints “Shigeki Ito”
- BylineArticles whose byline prints “Motoki Takano”
- BylineArticles whose byline prints “Yoji Ishida”
